YELP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
YELP is not a good buy right now. The trend is still bearish (SMA_200 > SMA_20 > SMA_5, MACD below zero), insiders are selling aggressively, and the near-term pattern odds skew negative over the next month. With no proprietary buy signals today and no fresh news catalyst, the risk/reward favors avoiding new entries (or trimming if already long) rather than buying immediately.
Price 27.38 is sitting just above first support (S1=27.182) and below the pivot (28.183), keeping the stock in a weak technical position. Moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), confirming a downtrend. MACD histogram is negative (-0.184) though contracting, which can indicate downside momentum is slowing but not reversed. RSI(6)=27.8 is near oversold conditions, so a short-term bounce is possible, but it’s not a confirmed trend reversal. Key levels: hold above 27.18 to avoid a move toward S2=26.56; bulls need a reclaim of 28.18 (pivot) and then 29.18 (R1) to improve the setup.
Intellectia Proprietary Trading Signals
on 2026-02-12 after hours, which could reset expectations if results/guide surprise positively. Options skew (call-heavy) suggests some market participants are positioned for upside.
Downtrend intact (bearish MA stack; MACD still below zero) and probabilistic pattern outlook points to ~-5.53% over the next month. Insiders are selling heavily (selling amount up ~573% over the last month), which is a notable negative signal. Analyst commentary highlights muted growth and ad-budget softness; also recurring concern around AI disintermediation limiting multiple expansion. No supportive news flow in the past week to change sentiment.
Latest quarter: 2025/Q3. Revenue grew to $376.0M (+4.36% YoY), net income rose to $39.3M (+2.30% YoY), EPS increased to $0.61 (+8.93% YoY). Growth is positive but modest, and gross margin declined to 87.02% (-1.59% YoY), suggesting some margin pressure versus last year.
Recent analyst actions are mixed-to-cautious with price targets generally coming down: Evercore kept Outperform but cut PT to $38 from $45 (mixed Q3; weaker Q4 guidance). JPMorgan maintained Neutral and cut PT to $30 from $33 (growth seen as muted until ad budgets improve). Jefferies reiterated Hold and nudged PT to $32 (concerns about incremental spend limiting margin expansion and AI disintermediation). Wall Street pros: product innovation and new revenue streams could help. Cons: near-term growth muted, guidance pressure, AI/multiple-risk narrative, and limited upside without an ad-spend reacceleration.
Politicians/influential figures: No recent Congress trading data available; no politician activity indicated in the provided data.
